Status:
RECRUITING
Percutaneous Peritoneal Dialysis Catheter Insertion (PREDICT)
Lead Sponsor:
Universitair Ziekenhuis Brussel
Collaborating Sponsors:
UMC Utrecht
Leiden University Medical Center
Conditions:
End-stage Kidney Disease
Eligibility:
All Genders
18+ years
Brief Summary
Peritoneal dialysis (PD) is the most frequent modality of home dialysis for patients with kidney failure. Most PD catheters are placed using a laparoscopic technique. This approach requires the avail...
Detailed Description
The population of the PREDICT study are adult patients requiring a peritoneal dialysis catheter insertion. Decision for percutaneous strategy of catheter insertion (versus surgical catheter insertion)...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Percutaneous PD catheter insertion between March 1st 2023 and March 1st 2026 Patients can be included 4 weeks before until 12 weeks after PD catheter insertion
Exclusion
- Inability to provide informed consent
- Life expectancy \< 3 months
Key Trial Info
Start Date :
June 23 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 23 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06065982
Start Date
June 23 2023
End Date
June 23 2027
Last Update
October 4 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Brussel
Brussels, Belgium, 1090
2
UMC Utrecht
Utrecht, Netherlands